A serious global public health concern, Sexually Transmitted Infections (STIs) are becoming more prevalent in diverse locations. The increased prevalence of STDs is significantly influencing the market for women's sexual wellness. It greatly impacts creating and expanding goods and services to enhance sexual health and well-being. Infertility, cervical cancer, and increased susceptibility to HIV are just a few of the long-term effects of STDs and the immediate health hazards they present. Promoting sexual welfare among women worldwide requires addressing the rising rates of STDs.
Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-europe-and-asia-pacific-women-sexual-wellness-market
According to the Centers for Disease Control and Prevention (CDC), the U.S. and Canada have been experiencing a steady increase in the number of reported STD cases
In 2021, in the U.S., there were approximately 1.56 million reported cases of chlamydia, a slight increase compared to previous years. Young women aged 15 to 24 continue to be disproportionately affected by this infection
The demand for preventive products, testing services, educational resources, and supportive interventions rises as women prioritize their sexual health in response to the growing prevalence of STDs. This trend emphasizes the importance of ongoing efforts to educate, empower, and provide comprehensive sexual wellness solutions for women in these regions. Hence, growing incidences of sexually transmitted diseases are expected to drive the market growth.
Data Bridge Market Research analyses that the North America, Europe and Asia-Pacific Women Sexual Wellness Market is expected to grow with a CAGR of 9.7% in North America, 10.1% in Europe, and 11.7% in Asia-Pacific in the forecast period from 2023 to 2030, and is expected to reach USD 2,599.39 million in North America, 665.94 million in Europe and 466.43 million in Asia-Pacific by 2030. In 2023, the Human Papillomavirus (HPV) Testing segment is expected to dominate the market due to growth as they detect the presence of high-risk HPV types, even without visible cervical abnormalities.
Key Findings of the Study
- GROWING AWARENESS ABOUT STDS IN WOMEN SEXUAL WELLNESS MARKET.
Sexually Transmitted Diseases (STDs) have recently become a major global public health concern. Therefore, more knowledge of STDs and how they affect women's sexual wellness is being spread. This rising awareness catalyzes the creation and expanding goods and services to enhance sexual health and well-being.
- In North America, concerted efforts have been made to raise awareness about STDs and promote sexual wellness among women
- The CDC's "Let's Talk Month" and "GYT: Get Yourself Tested" campaigns encourage open conversations about sexual health and promote regular testing for STDs. These initiatives have contributed to increased awareness and testing rates among women
The growing awareness about STDs in North America, Europe, and the Asia-Pacific region has played a crucial role in promoting sexual wellness among women. Efforts such as awareness campaigns, education programs, and accessible resources have contributed to increased knowledge about STDs, safer sex practices, and the importance of regular testing. This heightened awareness has driven the demand for preventive measures, testing services, and supportive interventions in the women's sexual wellness market, emphasizing the significance of ongoing efforts to educate and empower women in their sexual health journey. Therefore, growing awareness about STDs is expected to drive market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in Million, Pricing in USD
|
|
Segments Covered
|
Test Type (Chlamydia Trachomatis And Neisseria Gonorrhoeae (CT/NG) Test, HCV Test, HIV Test, Cervical Cancer, Tuberculosis, Bacterial Vaginosis, Human Papillomavirus (HPV) Testing, Genital Herpes, Viral Complications With Transplant, and Others), Test Location (Over-The-Counter Testing, Self-Collection/ At Home Testing, Point-Of-Care Testing and Others), Technology (Molecular, Serology, Culture/ Isolation Of Organism, and Others), End User (Hospitals, Clinics, Diagnostic Centers, Laboratories, Home Care Setting, and Others), Distribution Channel (Online and Offline),
|
|
Countries Covered
|
U.S., Canada, Germany, France, U.K, China, Japan, and Australia
|
|
Market Players Covered
|
Trinity Biotech(Ireland), BIOMÉRIEUX(France), Accuquik Test Kits (U.S.), JOYSBIO (Tianjin) Biotechnology Co., Ltd(China), Arbor Vita(U.S.), Randox Laboratories Ltd.(U.K.), Chembio Diagnostics, Inc.(U.S.), Cepheid (U.S.), ELITech Group(Italy), Abbott(U.S.), F. Hoffmann-La Roche Ltd.(Switzerland), Bio-Rad Laboratories, Inc.(U.S.), Sekisui Diagnostics (A Part of SEKISUI Chemical Co. Ltd.)(U.S.), Quidel Corporation(U.S.), BD.(U.S.), OraSure Technologies(U.S.), Hologic, Inc.(U.S.), and Biomed Diagnostics(U.S.) among others.
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The market is segmented into five notable segments such as test type, test location, technology, end user, and distribution channel.
- On the basis of test type, the market is segmented into Chlamydia Trachomatis and Neisseria Gonorrhoea (CT/NG) test, HCV test, HIV test, cervical cancer, tuberculosis, bacterial vaginosis, Human Papillomavirus (HPV) testing, genital herpes, viral complications with transplant and others.
In 2023, the Human Papillomavirus (HPV) testing segment is expected to dominate the market
In 2023, the Human Papillomavirus (HPV) testing segment is expected to dominate the market with 22.00% market share in North America, 24.30% in Europe, and 26.84% in Asia-Pacific due to growing awareness about STDS in women sexual wellness market.
- On the basis of test location, the market is segmented into over-the-counter testing, self-collection/ at home testing, Point-Of-Care Testing, and others. In 2023, the point-of-care testing segment is expected to dominate the market with 53.02% market share in North America, 45.99% in Europe, and 48.08% in Asia-Pacific.
- On the basis of technology, the market is segmented into molecular, serology, culture/ isolation of organism, and others.
In 2023, the serology segment is expected to dominate the market
In 2023, the serology segment is expected to dominate the market with 55.32% in North America, 56.87% in Europe, and 58.57% in Asia-Pacific due to growing awareness about STDS in women sexual wellness market.
- On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, laboratories, home care setting, and others. In 2023, the hospitals segment is expected to dominate the market with 26.69% in North America, 29.10% in Europe, and 31.75% in Asia-Pacific.
- On the basis of distribution channel, the market is segmented into online and offline. In 2023, the offline segment is expected to dominate the market with 78.05% in North America, 78.31% in Europe, and 78.61% in Asia-Pacific.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in North America, Europe and Asia-Pacific Women Sexual Wellness Market are Trinity Biotech(Ireland), BIOMÉRIEUX(France), Accuquik Test Kits.(U.S.), JOYSBIO (Tianjin) Biotechnology Co., Ltd(China), Arbor Vita(U.S.), Randox Laboratories Ltd.(U.K.), Chembio Diagnostics, Inc.(U.S.), Cepheid.(U.S.), ELITech Group(Italy), Abbott(U.S.), F. Hoffmann-La Roche Ltd.(Switzerland), Bio-Rad Laboratories, Inc.(U.S.), Sekisui Diagnostics (A Part of SEKISUI Chemical Co. Ltd.)(U.S.), Quidel Corporation(U.S.), BD.(U.S.), OraSure Technologies(U.S.), Hologic, Inc.(U.S.), and Biomed Diagnostics(U.S.) among others.
Market Development
- In March 2023, Trinity Biotech plc welcomed the announcement by the Kenyan Ministry of Health of the adoption of a new HIV rapid testing algorithm. This new algorithm establishes Trinity Biotech’s TrinScreen HIV as the screening test (A1 = screen test under World Health Organisation (“WHO”) guidelines)
- In February 2022, Trinity Biotech plc (Nasdaq: TRIB) received approval for its new HIV screening product, TrinScreen HIV, from the World Health Organisation (WHO)
- In April 2023, Oxford Nanopore Technologies plc, the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the field of in vitro diagnostics, announced that they have teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market
- In April 2023, ELITech Group unveils plans for its next innovation: launching a high throughput sample-to-result instrument for molecular diagnostics. ELITech Group continues to expand its portfolio of molecular solutions to support laboratories worldwide. The company’s new molecular high throughput system is designed for maximum flexibility and will be launched in 2024
- In November 2022, Cepheid announced that it had launched Xpert Xpress MVP, a multiplexed PCR test that detects DNA from organisms associated with three distinct conditions – bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis – from a single sample, aiding in more accurate diagnosis and antibiotic treatment regimens
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada, Germany, France, U.K, China, Japan, and Australia as per Data Bridge Market Research analysis:
North America is the dominant region in North America, Europe and Asia-Pacific Women Sexual Wellness Market during the forecast period 2023 -2030
In 2023, North America dominated the market owing to the higher level of investments by various manufacturers for women’s sexual wellness and increasing technological advancements in the region. North America will continue to dominate the market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period.
Asia-Pacific is estimated to be the fastest-growing region in the market during the forecast period 2023-2030. This is due to the growing adoption of advanced technology and the launch of new products in this region, also growing awareness for STDs in the region.
For more detailed information about the Women Sexual Wellness Market report, click here – https://www.databridgemarketresearch.com/reports/north-america-europe-and-asia-pacific-women-sexual-wellness-market
